Lansoprazole Capsule, Delayed Release
Product Images NDC 51407-324

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 51407-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-324-01lb.jpg (51407 324 01lb)

Label for Lansoprazole delayed-release capsules, USP, 30 mg strength. The package contains 100 capsules and is labeled with NDC 51407-324-01. The label includes storage instructions at 20° to 25°C and a caution to keep out of reach of children. Manufactured by Golden State Medical Supply, Inc. This is a prescription-only medication as indicated by 'Rx only.' Barcode and lot, expiry, and serial number fields are present but not filled.*

FDA Label Image

Figure-1.jpg (Figure 1)

A line graph showing the mean severity of day heartburn over time for evaluable patients receiving placebo, Lansoprazole 15 mg QD, and Lansoprazole 30 mg QD. Severity is rated from 0 (None) to 3 (Severe) on the y-axis, and days from start of treatment are plotted on the x-axis from -5 to 60. Lansoprazole groups show reduced heartburn severity compared to placebo over the treatment period.*

FDA Label Image

Figure-2.jpg (Figure 2)

A line graph showing the mean severity of night heartburn by study day for evaluable patients. The vertical axis represents the mean severity of night heartburn on a scale from 0 (none) to 3 (severe). The horizontal axis shows days from the start of treatment, ranging from -5 to 55. Three lines compare placebo, Lansoprazole 15 mg once daily (QD), and Lansoprazole 30 mg once daily (QD), illustrating a reduction in night heartburn severity over time, with the 30 mg dose showing the greatest decrease.*

FDA Label Image

Formula-structure.jpg (Image 01)

Chemical structure of Lansoprazole, showing its molecular formula with a benzimidazole ring linked to a substituted pyridine and a sulfoxide group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.